Serrato Paul, Hansen Justice, Ghanekar Shaila, Mitre Lucas P, DiLuna Michael, Elsamadicy Aladine A
1Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut; and.
2Faculty of Medicine, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
J Neurosurg Spine. 2025 Jul 25:1-11. doi: 10.3171/2025.4.SPINE2597.
The revised Risk Analysis Index (RAI-rev) and modified 5-item frailty index (mFI-5) are comprehensive assessment tools of frailty that have been used to predict neurosurgical outcomes. The aim of this study was to investigate the utility of these tools to predict extended hospital length of stay (LOS), nonroutine discharge (NRD), and 30-day adverse events (AEs) among patients with Chiari malformation type I (CM-I) undergoing suboccipital decompression.
The authors conducted a retrospective cohort study using the 2011-2022 American College of Surgeons National Surgical Quality Improvement Program database to identify adults with CM-I who underwent suboccipital decompression. Using receiver operating characteristic (ROC) curve and multivariable analyses, we compared the discriminative thresholds and independent associations of RAI-rev, mFI-5, and patient age, with extended LOS, NRD, and 30-day AEs.
Among 1225 patients studied, 806 patients (65.8%) were categorized as robust, 388 (31.7%) as typical and 31 (2.5%) as frail using RAI-rev, whereas 946 (77.2%) were categorized as robust, 222 (18.1%) as typical, and 57 (4.7%) as frail according to mFI-5. Multivariable analysis revealed RAI-rev (adjusted odds ratio [aOR] 4.37, 95% CI 1.40-13.70) and mFI-5 (aOR 2.71, 95% CI 1.38-5.32) scores as significant predictors of extended LOS for frail patients. RAI-rev was also a significant predictor of NRD for patients in the typical (aOR 2.57, 95% CI 1.00-6.60) and frail (aOR 15.70, 95% CI 3.27-75.44) groups. Neither the RAI-rev nor mFI-5 score significantly predicted 30-day AEs. On ROC analysis, there were no significant differences between the RAI-rev score (area under the curve [AUC] 0.5608), mFI-5 score (AUC 0.5626), and age (AUC 0.5496) in predicting LOS. Similarly, no differences were observed between the RAI-rev score, mFI-5 score, and age in predicting 30-day AEs. Notably, the RAI-rev score (AUC 0.7234) exhibited superior performance in predicting NRD compared with the mFI-5 score (p = 0.038) and age (p = 0.016).
The authors' findings demonstrate that while both RAI-rev- and mFI-5-defined frailty were significantly associated with extended LOS and NRD, RAI-rev outperformed mFI-5 in predicting NRD.
修订后的风险分析指数(RAI-rev)和改良的5项衰弱指数(mFI-5)是用于预测神经外科手术结局的综合衰弱评估工具。本研究的目的是探讨这些工具在预测枕下减压术治疗的I型Chiari畸形(CM-I)患者延长住院时间(LOS)、非常规出院(NRD)和30天不良事件(AE)方面的效用。
作者使用2011 - 2022年美国外科医师学会国家外科质量改进计划数据库进行了一项回顾性队列研究,以识别接受枕下减压术的CM-I成年患者。使用受试者操作特征(ROC)曲线和多变量分析,我们比较了RAI-rev、mFI-5和患者年龄的判别阈值及与延长LOS、NRD和30天AE的独立关联。
在1225例研究患者中,使用RAI-rev时,806例患者(65.8%)被归类为强健,388例(31.7%)为典型,31例(2.5%)为衰弱;而根据mFI-5,946例(77.2%)为强健,222例(18.1%)为典型,57例(4.7%)为衰弱。多变量分析显示,RAI-rev(调整后比值比[aOR]4.37, 95%可信区间[CI]1.40 - 13.70)和mFI-5(aOR 2.71, 95% CI 1.38 - 5.32)评分是衰弱患者延长LOS的显著预测因素。RAI-rev也是典型组(aOR 2.57, 95% CI 1.00 - 6.60)和衰弱组(aOR 15.70, 95% CI 3.27 - 75.44)患者NRD的显著预测因素。RAI-rev和mFI-5评分均未显著预测30天AE。在ROC分析中,RAI-rev评分(曲线下面积[AUC]0.5608)、mFI-5评分(AUC 0.5626)和年龄(AUC 0.5496)在预测LOS方面无显著差异。同样,在预测30天AE方面,RAI-rev评分、mFI-5评分和年龄之间也未观察到差异。值得注意的是,与mFI-5评分(p = 0.038)和年龄(p = 0.016)相比,RAI-rev评分(AUC 0.7234)在预测NRD方面表现更优。
作者的研究结果表明,虽然RAI-rev和mFI-5定义的衰弱均与延长LOS和NRD显著相关,但RAI-rev在预测NRD方面优于mFI-5。